Excipients, raw materials and intermediates

Biden executive order could impact pharmaceutical industry

13-Jul-2021 By Jenni Spinner

US President Joe Biden singled out the pharmaceutical industry in his recently issued Executive Order on Promoting Competition in the American Economy.

DCAT Week 2021 to take on industry education, innovation

24-Jun-2021 By Jenni Spinner

The annual event (scheduled July 12-16 online) will feature educational sessions, presentations, and networking opportunities for drug manufacturing pros.

Hot-melt extrusion can improve bioavailability: Avomeen

14-Jun-2021 By Jenni Spinner

With bioavailability challenges a frequent frustration for drug developers, one research outfit suggests a technique that could reduce the headaches.

People on the Move: June 2021

02-Jun-2021 By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

Tech Innovations: May 2021

19-May-2021 By Jenni Spinner

This month’s roundup of new equipment, technology partnerships, and other news includes items from Ajinomoto, Elligo, Syneos, ACD/Labs and other companies.

Online HPAPI Summit takes on key pharma ingredients topics

19-May-2021 By Jenni Spinner

The virtual event (scheduled June 22-24) will feature presentations from Bayer, Merck, GSK, Novartis, Takeda, FDA, WHO, and other notable organizations.

Ampac announces $25m expansion of pharma manufacturing facility

19-May-2021 By Jenni Spinner

The company is enhancing its Virginia facility to add an east coast presence for its Analytical Labs division and enhance R&D for pharma ingredients.

Novasep expands in France, sees increasing customer demand for ADC manufacturing services

14-May-2021 By Jane Byrne

Novasep has announced a further expansion of its Highly Potent Active Pharmaceutical Ingredients (HPAPIs) manufacturing capabilities at its Le Mans, France site, saying the move strengthens its position as a leading CDMO for the production of innovative...

Could synthetic biology solutions fix supply chain challenges?

11-May-2021 By Jenni Spinner

An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes.

‘Cognitive’ supply chain approach boosts safety, efficiency: FourKites

21-Jan-2021 By Jenni Spinner

A leader from the supply-chain specialist explains vulnerabilities and challenges unique to pharma, and how professionals can safeguard and streamline.

Continuus lands $69.3m US drug manufacturing contract

21-Jan-2021 By Jenni Spinner

The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions.

Lonza scientific team on the hunt for pharma fakery

13-Jan-2021 By Jenni Spinner

The company’s Forensic Chemistry Group comprises a collection of technical professionals using their respective talents to detect and thwart counterfeiting.

Pharmaceutical firms warming up to outsourcing: ReAgent

07-Jan-2021 By Jenni Spinner

A leader from the chemical manufacturing firm notes pharma companies are showing increased interest in contracting out their manufacturing functions.

Ingredients, innovation and a need for speed: what’s in store for 2021

23-Dec-2020 By Jenni Spinner

Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.

Supply chain woes can lead to billion-dollar problems: Cloudleaf

23-Dec-2020 By Jenni Spinner

A new survey from the supply-chain analysis company revals inefficiencies, inaccurate data and other flaws can be costly in terms of revenue, reputation and patient lives.

Stay on top of your pharma supply chain in 2021: PCI

17-Dec-2020 By Jenni Spinner

According to an executive from the drug development services company, pharma professionals should pay close attention to supply chain continuity and safety in the coming year.

People on the Move: November 2020

05-Nov-2020 By Jenni Spinner

The most recent news on pharmaceutical industry hires, promotions, acquisitions and other events includes Lonza, Medidata, Vetter, and Almac Group.

DFE Pharma: adoption of continuous manufacturing on the rise

04-Nov-2020 By Jenni Spinner

According to representatives from the pharma solutions provider, incorporation of CM processes, after a slow period, is expanding across the industry.

CPhI Festival of Pharma

CPhI Pharma Awards recognize industry achievements

19-Oct-2020 By Jenni Spinner

The 17th annual awards program, announced during the CPhI Festival of Pharma virtual event, hails professionals from various aspects of the industry.

SPI Pharma taps Thomson as CEO

15-Oct-2020 By Jenni Spinner

The pharma ingredients company has named veteran Scott Thomson, a 29-year veteran with chemicals firm BASF, to its executive leadership team.

CPhI Festival of Pharma

CPhI Pharma Index survey reveals minds of CEOs

01-Oct-2020 By Jenni Spinner

The survey, unveiled ahead of next week's CPhI Festival of Pharma, reveals perspectives, concerns and future plans of more than 500 industry executives.

CPhI Festival of Pharma

Hovione to boost output of COVID-19 treatment excipient

30-Sep-2020 By Jenni Spinner

The CPhI Festival of Pharma exhibitor will work with Ligand to increase output of Captisol, a key ingredient in Gilead’s Veklury COVID-19 treatment

CPhI Festival of Pharma

CPhI: SPI Pharma talks supply chain challenges

30-Sep-2020 By Jenni Spinner

The pharma ingredients provider discusses new products, supply-chain obstacles, and what the future of the industry might hold, ahead of the online event.

Seqens launches HPAPI manufacturing at 100-year-old site

14-Sep-2020 By Jenni Spinner

The global pharmaceutical ingredient producer has opened a high-potency active pharmaceutical ingredient unit at its century-old facility in France.

Ajinomoto grows small-molecule capabilities in India

18-Aug-2020 By Jenni Spinner

The CDMO is expanding its small-molecule manufacturing capacity with a new 8,500-square-meter production facility at its Visakhapatnam, India site.

Minakem: collaboration could elevate pharma supply chain

05-Aug-2020 By Jenni Spinner

Representatives from the CDMO offer perspective on problems plaguing the global pharma supply chain, and possible ways to improve them.

COVID-19 highlights US dependence on foreign pharma: CEO

05-Aug-2020 By Jenni Spinner

An executive from Pharmaceutical Associates Inc. believes bringing drug manufacturing back to the country will help avoid shortages and other disasters.

Senate bill proposes study of the US pharma supply chain

05-Aug-2020 By Jenni Spinner

The bipartisan bill calls for an assessment of the country’s pharma supply chain, including potential vulnerabilities and impact of foreign manufacturing.

TraceLink unveils FDA DSCSA pilot program results

05-Aug-2020 By Jenni Spinner

Initial information from the life-sciences specialist’s pilot program shows potential pathways to solving common pharma supply chain challenges.

Kodak Pharmaceuticals lands $765m US loan

30-Jul-2020 By Jenni Spinner

The imaging company’s newly launched division, created to produce drug ingredients, received the loan from the US International Development Finance Corp.

Colorcon expands pH range of enteric coatings

28-Jul-2020 By Jenni Spinner

The new Acryl-Eze II coatings line increases the pH range offered for delayed-release oral solid-dosage drugs and other items.

Absorption Systems: complex generics offer obstacles, opportunities

21-Jul-2020 By Jenni Spinner

A leader from the CRO shares perspectives on the challenges and rewards associated with the category, and approaches in getting generics to market.

Evonik launches Resomer Precise custom functional excipients

15-Jun-2020 By Jenni Spinner

The company reportedly is harnessing sophisticated technology to enable process validation of polymers to tight specifications in parenteral drugs.

People on the Move: June 2020

03-Jun-2020 By Jenni Spinner

This month’s roundup of new hires, promotions and awards involves Gilead Sciences, Cardiff Oncology, Science 37, and other notable firms.

SPI Pharma expands line of mannitol products

30-Mar-2020 By Jenni Spinner

The company has added four mannitols to its Mannogem line, designed for optimal compressibility, binding, disintegration and particle size ranges.

FDA reports first drug shortage due to coronavirus outbreak

02-Mar-2020 By Vassia Barba

The US FDA announces shortage of a drug due to a site affected by coronavirus, as it focuses on the protection of the supply chain from outbreak impacts.

Sun Pharma blames 'speculative buying' on coronavirus-related price hikes

17-Feb-2020 By Nick Taylor

Sun Pharma argues rising ingredient and finished product prices are unjustified, blames ‘speculative buying’ for trend.

Pfizer's CDMO unit drives growth at hospital business

03-Feb-2020 By Nick Taylor

Pfizer attributes performance of contract manufacturing unit as driver of growth at hospital business.

FDA's Woodcock details national security risks of global supply chains

07-Nov-2019 By Nick Taylor

FDA’s Janet Woodcock testifies to Congress about the potential risks to US national security of the pharmaceutical industry’s reliance on Chinese imports.

GSK and AZ on continuous manufacturing platform ‘grand challenge’

14-Oct-2019 By Vassia Barba

A consortium between CPI and the University of Strathclyde aims to create a direct compression platform for continuous manufacturing of oral solid dosage drugs.

The five potential sources of nitrosamine contamination

02-Oct-2019 By Ben Hargreaves

With nitrosamines back in the headlines due to the recent discovery of contaminants in ranitidine, the EMA releases the five potential causes of the impurities plaguing the industry.

LBB to supply Meggle’s excipients in the US market

05-Sep-2019 By Vassia Barba

LBB takes on the marketing and distribution of Meggle’s lactose-based excipients for direct compression and inhalation in the US market.

Analysis finds bulk of warnings delivered to Indian and Chinese drugmakers

30-Aug-2019 By Ben Hargreaves

The US market is dependent upon API and generic drugs produced in India and China, yet these countries also received the majority of warning letters issued by the US FDA.

Pharmaceutical excipients market to hit $9.8bn by 2025

28-Aug-2019 By Vassia Barba

Bolstered by manufacturing advancements, the global revenues of the pharmaceutical excipients market are expected to grow at a CAGR of 5.8% in the coming years.

Switzerland upgrades tests to boost detection of sartan impurities

09-Aug-2019 By Nick Taylor

The Swiss Agency for Therapeutic Products revises the test it uses to assess whether sartan medicines are contaminated with nitrosamines.

Is ‘lack of control’ in supply chains the root cause of API impurities?

07-Aug-2019 By Maggie Lynch

API recalls have sparked discussion on the development of impurities during manufacturing and the ways in which risks can be mitigated, according to an industry expert.